Antagonism by the 5-HT2A/C receptor agonist DOI of raclopride-induced catalepsy in the rat

European Journal of Pharmacology

Volumn 294, Issue 1, 1995, Pages 247-251

  Wadenberg, Marie Louise ^a,b   Ahlenius, Sven ^a  

^a Department of Behavioral Pharmacology Astra Arcus AB ^*  (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

(Rat); 5 HT (5 hydroxytryptamine, serotonin); Catalepsy; Dopamine; Receptor

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; 5 HYDROXYTRYPTOPHAN; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BENSERAZIDE; DECARBOXYLASE INHIBITOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR; RACLOPRIDE; RITANSERIN; SEROTONIN 2 RECEPTOR; SEROTONIN 2A AGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2C AGONIST; SEROTONIN 2C ANTAGONIST; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; ZIMELDINE; 4-IODO-2,5-DIMETHOXYPHENYLISOPROPYLAMINE; AMPHETAMINE DERIVATIVE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; SALICYLAMIDE DERIVATIVE; SEROTONIN AGONIST; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; CATALEPSY; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; EXTRAPYRAMIDAL SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; CHEMICALLY INDUCED DISORDER; SPRAGUE DAWLEY RAT;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; 5-HYDROXYTRYPTOPHAN; AMPHETAMINES; ANIMALS; BENSERAZIDE; CATALEPSY; DOPAMINE AGENTS; DOPAMINE ANTAGONISTS; MALE; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; RITANSERIN; SALICYLAMIDES; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS; ZIMELDINE;

EID: 0029417149     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00535-8     Document Type: Article

References (31)

1. Involvement of extrapyramidal motor mechanisms in the suppression of locomotor activity by antipsychotic drugs: a comparison between the effects produced by pre- and postsynaptic inhibition of dopaminergic neurotransmission
2. Adjunctive fluoxetine in haloperidol-stabilized schizophrenics
3. Increase of cerebral catecholamines caused by 3, 4-dihydroxyphenylalanine after inhibitor of peripheral decar☐ylase
4. 2) receptors
5. 2 subtypes of dopamine receptors in rat brain
6. Effect of metergoline, fenfiuramine and 8-OH-DPAT on catalepsy induced by haloperidol or morphine
7. Behavioural effects of serotonin agonists and antagonists in the rat and marmoset
8. The influence of cerebral 5-hydroxytryptamine on catalepsy induced by brain-amine depleting neuroleptics or by cholinomimetics
9. 2 serotonin receptors
10. Role of 5-HT in the action of some drugs affecting extrapyramidal system
11. The effect of serotonergic agents on haloperidol-induced catalepsy
12. 5-HT receptor antagonist properties of SCH-23,390 in vascular smooth muscle and brain
13. 8-Hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT receptor stimulating activity
14. 2 recognition sites
15. A proposed new nomenclature for 5-HT receptors
16. 1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis
17. SCH 23390, a potential benzamide antipsychotic with unique interactions on dopaminergic systems
18. Interaction between fluoxetine and neuroleptics
19. 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the brain
20. Reduced cataleptogenic effects of some neuroleptics in rats with lesioned midbrain raphe and treated with p-chlorophenylalanine
21. 2)-receptor binding sites: effects of neuronal lesions
22. Reversal of neuroleptic-induced catalepsy by novel aryl-piperazine anxiolytic drugs
23. Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant
24. Serotonin receptors in the human brain-IV. Autoradiographic mapping of serotonin- 2 receptors
25. (Z)Dimethylamino-1-(4-bromophenyl)-1-(3-pyridyl)propene (H102/09), a new selective inhibitor of the neuronal 5-hydroxytryptamine uptake
26. Antagonism by 8-OH-DPAT, but not ritanserin, of catalepsy induced by SCH 23390 in the rat
27. Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy
28. 1A autoreceptors by the local application of 8-OH-DPAT reverses raclopride-induced catalepsy in the rat
29. Supraspinal mediation of dopamine-serotonin interactions in extrapyramidai motor functions in the rat
30. Serotonin-dopamine interactions in the nigrostriatal system